Skip to main content
Focused investors/ValueAct Capital

ValueAct Capital

As of Q2 2026, ValueAct Capital reported 18 long-equity positions worth $5.63B in aggregate.

Copy-investor backtest

Latest quarter
+11.81%
1-year
-6.13%
3-year
+68.78%
5-year
+54.42%
3-year vs S&P 500
-4.46%
5-year vs S&P 500
-19.26%
5-year top 5
+37.05%

Return from mechanically copying the disclosed 13F equity portfolio after each filing and rebalancing at the next. The vs S&P 500 figures subtract SPY over that manager's own rebalance dates, so both sides cover the same days; both are price return, excluding dividends. Method & limitations.

Get email alerts when ValueAct Capital files a new 13F — sign in or create a free account.

Updated 2026-06-06 from SEC 13F data.

Live quotes available for 10 of 13 rows. Rows without a quote are marked unavailable.

1STXSEAGATE TECHNOLOGY PLC21.74%Reduce -4.5%30,146,673$1.87B$62.1652w: $39.02 - $66.69; reported $62.16
2CCITIGROUP INC19.33%-27,025,500$1.67B$61.6652w: $32.00 - $83.11; reported $61.66
3KKRKKR & CO INC17.87%Reduce -15.4%38,050,000$1.54B$40.4952w: $15.55 - $40.71; reported $40.49
4LKQLKQ CORP8.81%-21,547,746$759.34M$35.2452w: $13.31 - $38.38; reported $35.24
5TRNTRINITY INDS INC8.27%-27,005,855$712.69M$26.3952w: $14.53 - $26.87; reported $26.39
6CBRECBRE GROUP INC7.44%-10,229,820$641.61M$62.7252w: $29.17 - $67.70; reported $62.72
7MSMORGAN STANLEY6.58%Reduce -28.0%8,283,722$567.68M$68.5352w: $27.20 - $68.97; reported $68.53
8SLMSLM CORP4.64%-32,294,254$400.13M$12.3952w: $5.60 - $12.55; reported $12.39
9BHCBAUSCH HEALTH COS INC4.33%Add +0.1%17,941,603$373.19M$20.8052w: $11.15 - $30.39; reported $20.80
10CDWCDW CORP0.56%Add +53.6%368,116$48.51M$131.7952w: $73.39 - $146.95; reported $131.79
11FIFISERV INC0.43%New328,281$37.38MNo quoteNo quote
13AOSSMITH A O CORP-Sold0$0No quoteNo quote
12AFIIQARMSTRONG FLOORING INC-Sold0$0No quoteNo quote